Additionally, the expression of CDKN1A and CDKN2A, as well as the presence of TAF, has been observed in non-alcoholic fatty liver disease, and TAF has also been reported in alcoholic liver disease (109). This evidence concerns the gene CDKN2A and metabolic dysfunction-associated steatotic liver disease.